VisiDome

Company Overview

Snapshot

Founded in October 2013 by Nir Betser and Prof. Ehud Assia, VisiDome operates with 1–10 employees. The company secured one funding round from two investors. In February 2023, VisiDome ceased operations.

Business overview

VisiDome specializes in developing an add-on accommodative intraocular lens (IOL) designed to restore clear vision for cataract patients across all distances, thereby eliminating the need for glasses post-surgery. The company's technology leverages the ciliary muscle and efficient shape-changing optics to achieve a broad range of accommodation. VisiDome operates within the Health Tech & Life Sciences sector, specifically focusing on medical devices and ophthalmology.

Company Intelligence Q&A

What is VisiDome's primary product?

VisiDome is developing an accommodative intraocular lens (IOL) that aims to restore cataract patients' ability to focus clearly on objects at any distance, eliminating the need for glasses after surgery.

When was VisiDome founded and by whom?

VisiDome was founded in October 2013 by Nir Betser and Prof. Ehud Assia.

What is the current operational status of VisiDome?

VisiDome ceased operations in February 2023.

Which investors participated in VisiDome's funding round?

In December 2015, VisiDome received funding from The Trendlines Group and Mor Research Applications.

What technology is central to VisiDome's IOL?

VisiDome's IOL technology harnesses the strength of the ciliary muscle combined with efficient shape-changing optics to guarantee a large magnitude of accommodation for a wide and sufficient range of clear vision.